Cytokine Regulation of P-Glycoprotein

REFERENCES

• Akazawa Y., Kawaguchi H., Funahashi M., Watanabe Y., Yamaoka K., Hashida M., Takakura Y. Effect of interferons on P-glycoprotein-mediated rhodamine-123 efflux in cultured rat hepatocytes. J. Pharm. Sci. 2002; 91(10)2110–2115
   PubMed Web of Science ®Google Scholar
• Bertilsson P. M., Olsson P., Magnusson K. E. Cytokines influence MRNA expression of cytochrome P450 3A4 and MDRI in intestinal cells. J. Pharm. Sci. 2001; 90(5)638–646
   PubMed Web of Science ®Google Scholar
• Fantuzzi G., Dinarello C. A. The inflammatory response in interleukin-1 beta-deficient mice: comparison with other cytokine-related knock-out mice. J. Leukoc. Biol. 1996; 59(4)489–493
   PubMed Web of Science ®Google Scholar
• Fellay J., Marzolini C., Meaden E. R., Back D. J., Buclin T., Chave J. P., Decosterd L. A., Furrer H., Opravil M., Pantaleo G., Retelska D., Ruiz L., Schinkel A. H., Vernazza P., Eap C. B., Telenti A. Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study. Lancet 2002; 359(9300)30–36
   PubMed Web of Science ®Google Scholar
• Hartmann G., Kim H., Piquette-Miller M. Regulation of the hepatic multidrug resistance gene expression by endotoxin and inflammatory cytokines in mice. Int. Immunopharmacol. 2001; 1(2)189–199
   PubMed Web of Science ®Google Scholar
• Heinrich P. C., Castell J. V., Andus T. Interleukin-6 and the acute phase response. Biochem. J. 1990; 265(3)621–636
   PubMed Web of Science ®Google Scholar
• Hirsch-Ernst K. I., Ziemann C., Foth H., Kozian D., Schmitz-Salue C., Kahl G. F. Induction of Mdr1b MRNA and P-glycoprotein expression by tumor necrosis factor alpha in primary rat hepatocyte cultures. J. Cell. Physiol. 1998; 176(3)506–515
   PubMed Web of Science ®Google Scholar
• Hochman J. H., Chiba M., Yamazaki M., Tang C., Lin J. H. P-glycoprotein-mediated efflux of indinavir metabolites in Caco-2 cells expressing cytochrome P450 3A4. J. Pharmacol. Exp. Ther. 2001; 298(1)323–330
   PubMed Web of Science ®Google Scholar
• Hoffmeyer S., Burk O., von Richter O., Arnold H. P., Brockmoller J., Johne A., Cascorbi I., Gerloff T., Roots I., Eichelbaum M., Brinkmann U. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc. Natl Acad. Sci. USA 2000; 97(7)3473–3478
   PubMed Web of Science ®Google Scholar
• Huang L., Wring S. A., Woolley J. L., Brouwer K. R., Serabjit-Singh C., Polli J. W. Induction of P-glycoprotein and cytochrome P450 3A by HIV protease inhibitors. Drug Metab. Dispos. 2001; 29(5)754–760
   PubMed Web of Science ®Google Scholar
• Ito S., Ieiri I., Tanabe M., Suzuki A., Higuchi S., Otsubo K. Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/CMOAT, in healthy Japanese subjects. Pharmacogenetics 2001; 11(2)175–184
   PubMedGoogle Scholar
• Kang Y., Perry R. R. Effect of alpha-interferon on P-glycoprotein expression and function and on verapamil modulation of doxorubicin resistance. Cancer Res. 1994; 54(11)2952–2958
   PubMed Web of Science ®Google Scholar
• Kim R. B., Leake B. F., Choo E. F., Dresser G. K., Kubba S. V., Schwarz U. I., Taylor A., Xie H. G., McKinsey J., Zhou S., Lan L. B., Schuetz J. D., Schuetz E. G., Wilkinson G. R. Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin. Pharmacol. Ther. 2001; 70(2)189–199
   PubMed Web of Science ®Google Scholar
• Matheny C. J., Lamb M. W., Brouwer K. R., Pollack G. M. Pharmacokinetic and pharmacodynamic implications of P-glycoprotein modulation. Pharmacotherapy 2001; 21(7)778–796
   PubMed Web of Science ®Google Scholar
• Morgan E. T. Regulation of cytochromes P450 during inflammation and infection. Drug Metab. Rev. 1997; 29(4)1129–1188
   PubMed Web of Science ®Google Scholar
• Morgan E. T. Regulation of cytochrome P450 by inflammatory mediators: why and how?. Drug Metab. Dispos. 2001; 29(3)207–212
   PubMed Web of Science ®Google Scholar
• Piquette-Miller M., Pak A., Kim H., Anari R., Shahzamani A. Decreased expression and activity of P-glycoprotein in rat liver during acute inflammation. Pharm. Res. 1998; 15(5)706–711
   PubMed Web of Science ®Google Scholar
• Salphati L., Benet L. Z. Modulation of P-glycoprotein expression by cytochrome P450 3A inducers in male and female rat livers. Biochem. Pharmacol. 1998; 55(4)387–395
   PubMed Web of Science ®Google Scholar
• Smith A. J., Timmermans-Hereijgers J. L., Roelofsen B., Wirtz K. W., van Blitterswijk W. J., Smit J. J., Schinkel A. H., Borst P. The human MDR3 P-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice. FEBS Lett. 1994; 354(3)263–266
   PubMed Web of Science ®Google Scholar
• Stein U., Walther W., Shoemaker R. H. Modulation of Mdr1 expression by cytokines in human colon carcinoma cells: an approach for reversal of multidrug resistance. Br. J. Cancer 1996a; 74(9)1384–1391
   PubMed Web of Science ®Google Scholar
• Stein U., Walther W., Shoemaker R. H. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells. J. Natl Cancer Inst. 1996b; 88(19)1383–1392
   PubMed Web of Science ®Google Scholar
• Sukhai M., Yong A., Kalitsky J., Piquette-Miller M. Inflammation and interleukin-6 mediate reductions in the hepatic expression and transcription of the Mdr1a and Mdr1b genes. Mol. Cell Biol. Res. Commun. 2000; 4(4)248–256
   PubMedGoogle Scholar
• Sukhai M., Yong A., Pak A., Piquette-Miller M. Decreased expression of P-glycoprotein in interleukin-1beta and interleukin-6 treated rat hepatocytes. Inflamm. Res. 2001; 50(7)362–370
   PubMed Web of Science ®Google Scholar
• Talamini M. A., Kappus B., Hubbard A. Repolarization of hepatocytes in culture. Hepatology 1997; 25(1)167–172
   PubMed Web of Science ®Google Scholar
• Trauner M., Arrese M., Soroka C. J., Ananthanarayanan M., Koeppel T. A., Schlosser S. F., Suchy F. J., Keppler D., Boyer J. L. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 1997; 113(1)255–264
   PubMed Web of Science ®Google Scholar
• Vos T. A., Hooiveld G. J., Koning H., Childs S., Meijer D. K., Moshage H., Jansen P. L., Muller M. Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver. Hepatology 1998; 28(6)1637–1644
   PubMed Web of Science ®Google Scholar
• Walther W., Stein U. Influence of cytokines on Mdr1 expression in human colon carcinoma cell lines: increased cytotoxicity of MDR relevant drugs. J. Cancer Res. Clin. Oncol. 1994; 120(8)471–478
   PubMed Web of Science ®Google Scholar
• Walther W., Stein U., Pfeil D. Gene transfer of human TNF alpha into glioblastoma cells permits modulation of Mdr1 expression and potentiation of chemosensitivity. Int. J. Cancer 1995; 61(6)832–839
   PubMed Web of Science ®Google Scholar